How much funding has Beta Bionics, Inc. raised?

Beta Bionics, Inc. has raised $275.6M in total funding, most recently a Series E round.

Who are Beta Bionics, Inc.'s investors?

Beta Bionics, Inc.'s investors include Wellington Management, Sands Capital, Eventide Asset Management, RTW Investments, Omega Funds, Marshall Wace.

When was Beta Bionics, Inc. founded?

Beta Bionics, Inc. was founded in 2018.

Where is Beta Bionics, Inc. headquartered?

Beta Bionics, Inc. is headquartered in Boston, Massachusetts, United States.

What industry is Beta Bionics, Inc. in?

Beta Bionics, Inc. operates in Digital Health, Healthcare, medical devices, Medical Devices.

How many employees does Beta Bionics, Inc. have?

Beta Bionics, Inc. has 11-50 employees.

Beta Bionics, Inc.

IPO

iLet Bionic Pancreas – the insulin pump that automatically learns and adapts to you.

Boston, United States · Founded 2018 · $275.6M raised

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2018
Business Model: B2C

Website: betabionics.com
Total Funding: $275.6M
Last Round: $60.0M Series ENov 2024
Rounds: 5

About

Beta Bionics is a Boston-based medical device company dedicated to making diabetes management easier. The company developed the iLet Bionic Pancreas, an FDA-cleared automated insulin delivery system for people with type 1 diabetes aged 6 and older. The iLet uses continuous glucose monitor data to autonomously calculate and deliver all insulin doses without carb counting.

Summary

Beta Bionics, Inc. is a Digital Health company based in Boston, United States, founded in 2018. It has raised $275.6M in total across 5 rounds, most recently a $60.0M Series E round in Nov 2024. Investors include Wellington Management, Sands Capital and Eventide Asset Management.